In our study, the presence of the pluripotency-related markers Oct4, Sox2, and Nanog and the protooncogenic markers p53, p21, and c-myc in primary ovarian cancer cells and immortalized ovarian cancer cells was confirmed using the RT PCR and/or immunofluorescence staining. The gene discussed is MYC; the disease is ovarian carcinoma.